One can hypothesize that AhR activation would abrogate the adverse role of KYNA in atherosclerosis development in IDO-deficient mice because it is known, for example, that AhR promotes IL-10 expression in inflammatory macrophages via the nongenomic Src–STAT3 signaling pathway [334]. The gene discussed is IL10; the disease is atherosclerosis.